{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:25:24Z","timestamp":1790259924729,"version":"4.1.0"},"reference-count":55,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["SAGE Open Medicine"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Viral hepatitis, particularly hepatitis B virus and hepatitis C virus, is the leading cause of global liver-related morbidity and mortality. Concomitant infections of hepatitis B virus, hepatitis C virus, and tuberculosis are risks of hepatotoxicity and death due to antituberculosis therapy. Hepatitis and human immunodeficiency virus coinfection poses challenges in treating hepatotoxic patients and leads to mortality during antituberculosis treatment. Thus, this study aimed to determine the prevalence of hepatitis B virus and hepatitis C virus infections, and associated factors among human immunodeficiency virus-positive and human immunodeficiency virus-negative tuberculosis patients attending public health facilities, Northeast Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comparative cross-sectional study was conducted among 229 tuberculosis patients from January 1 to April 30, 2021 in public health facilities\u2019 tuberculosis treatment centers. Study participants were selected using a consecutive sampling technique. Data on sociodemographic and other risk factors were collected using an interviewer-based pretested questionnaire by trained data collectors. Anti-hepatitis C virus and hepatitis B surface antigen were determined in serum using enzyme-linked immunosorbent assay. Data were entered and analyzed using SPSS version 22. Logistic regression analysis was computed, and then variables with a p value &lt;0.05 were considered as statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result:<\/jats:title>\n                    <jats:p>The overall hepatitis virus infection among human immunodeficiency virus-positive and human immunodeficiency virus-negative tuberculosis patients was 14.03% and 8.14%, respectively. The prevalence of hepatitis B virus infection in human immunodeficiency virus positives and human immunodeficiency virus negatives was 10.5% and 6.4% and hepatitis C virus infection in human immunodeficiency virus positives and human immunodeficiency virus negatives was 3.5% and 1.75%, respectively. Hepatitis B virus and hepatitis C virus coinfections were not observed. Older age, history of problematic alcohol use, history of blood transfusion, ear\u2013noise piercing, and history of multiple heterosexual partners were predictors for the hepatitis virus infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Hepatitis virus infection increases morbidity and mortality of tuberculosis patients. Therefore, screening tuberculosis patients for hepatitis virus infection is necessary to reduce the risk of antituberculosis complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20503121231166642","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T07:11:08Z","timestamp":1682406668000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatitis B and C virus infections and associated factors among HIV-positive and HIV-negative tuberculosis patients in public health facilities, Northeast Ethiopia: A comparative cross-sectional study"],"prefix":"10.1177","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-5513","authenticated-orcid":false,"given":"Alemu","family":"Gedefie","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurahaman","family":"Seid","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genet","family":"Molla Fenta","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2343-2119","authenticated-orcid":false,"given":"Mihret","family":"Tilahun","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6286-7564","authenticated-orcid":false,"given":"Agumas","family":"Shibabaw","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"bibr1-20503121231166642","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020395"},{"issue":"4","key":"bibr2-20503121231166642","first-page":"1718","volume":"9","author":"Bane A","year":"2014","journal-title":"Int J Innov Appl Stud"},{"key":"bibr3-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy144"},{"key":"bibr4-20503121231166642","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis. Switzerland, Geneva: WHO, 2016, pp. 1\u201353."},{"key":"bibr5-20503121231166642","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i10.1377"},{"key":"bibr6-20503121231166642","volume-title":"Hepatitis B virus","author":"World Health Organization","year":"2019"},{"key":"bibr7-20503121231166642","volume-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections","author":"World Health Organization","year":"2021"},{"key":"bibr8-20503121231166642","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v6.i13.589"},{"key":"bibr9-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27410"},{"key":"bibr10-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.04.006"},{"issue":"1","key":"bibr11-20503121231166642","first-page":"1","volume":"3","author":"Sama LF","year":"2017","journal-title":"Glob J Infect Dis Clin Res"},{"key":"bibr12-20503121231166642","unstructured":"CDC Department of Health and Human Services. Action plan for the prevention, care, and treatment of viral hepatitis update 2014\u20132016. Atlanta, GA: CDC, 2014, pp. 1\u2013100."},{"key":"bibr13-20503121231166642","volume-title":"Global hepatitis report","author":"World Health Organization","year":"2017"},{"key":"bibr14-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.005"},{"key":"bibr15-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4456-0"},{"key":"bibr16-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmyco.2016.06.019"},{"key":"bibr17-20503121231166642","doi-asserted-by":"publisher","DOI":"10.26719\/2013.19.7.589"},{"key":"bibr18-20503121231166642","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0636"},{"key":"bibr19-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268813002355"},{"issue":"1","key":"bibr20-20503121231166642","first-page":"8","volume":"1","author":"Juhar S","year":"2018","journal-title":"J Interve Nephrol"},{"key":"bibr21-20503121231166642","doi-asserted-by":"publisher","DOI":"10.5897\/AJMR2015.7583"},{"key":"bibr22-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcdt.2015.08.009"},{"issue":"1","key":"bibr23-20503121231166642","first-page":"13","volume":"1","author":"Pennap G","year":"2018","journal-title":"J Transl Gastroenterol Clin Hepatol"},{"issue":"4","key":"bibr24-20503121231166642","first-page":"17","volume":"7","author":"Abdelsalam M","year":"2012","journal-title":"Sudan JMS"},{"key":"bibr25-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083892"},{"key":"bibr26-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760160352"},{"key":"bibr27-20503121231166642","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i29.8920"},{"key":"bibr28-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.06.020"},{"key":"bibr29-20503121231166642","doi-asserted-by":"publisher","DOI":"10.17554\/j.issn.2224-3992.2016.05.670"},{"issue":"1","key":"bibr30-20503121231166642","first-page":"16","volume":"4","author":"Singh K","year":"2016","journal-title":"Int J Sci Study"},{"issue":"133","key":"bibr31-20503121231166642","first-page":"1","volume":"17","author":"Feleke BE","year":"2020","journal-title":"Virol J"},{"key":"bibr32-20503121231166642","first-page":"1","author":"Fosgate G","year":"2006","journal-title":"Comput Methods Geosci"},{"issue":"17","key":"bibr33-20503121231166642","first-page":"1","volume":"300","author":"Ewing JA","year":"2008","journal-title":"JAMA"},{"key":"bibr34-20503121231166642","volume-title":"CAGE substance abuse screening tool","author":"Johns Hopkins Medicine","year":"1984"},{"key":"bibr35-20503121231166642","doi-asserted-by":"publisher","DOI":"10.4038\/sljid.v8i2.8219"},{"key":"bibr36-20503121231166642","doi-asserted-by":"publisher","DOI":"10.17352\/2455-5363.000001"},{"key":"bibr37-20503121231166642","doi-asserted-by":"publisher","DOI":"10.17352\/2455-5363.000001"},{"issue":"380","key":"bibr38-20503121231166642","first-page":"1","volume":"19","author":"Pappoe F","year":"2019","journal-title":"BMC Infect Dis"},{"key":"bibr39-20503121231166642","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v15i2.3"},{"key":"bibr40-20503121231166642","unstructured":"WHO. Management of hepatitis B and HIV co-infection. Geneva, Switzerland: WHO, 2011, pp. 1\u201325."},{"issue":"7","key":"bibr41-20503121231166642","first-page":"12","volume":"110","author":"Oakes K.","year":"2014","journal-title":"Nurs Times"},{"key":"bibr42-20503121231166642","first-page":"69","volume":"29","author":"Akhtar J","year":"2013","journal-title":"Biomedica"},{"key":"bibr43-20503121231166642","first-page":"996","volume":"88","author":"Araujo-Mariz C","year":"2016","journal-title":"Antivir Ther"},{"key":"bibr44-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-017-0136-0"},{"key":"bibr45-20503121231166642","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2018.00016"},{"key":"bibr46-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12644"},{"key":"bibr47-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.363"},{"key":"bibr48-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0896-7"},{"issue":"110","key":"bibr49-20503121231166642","first-page":"1","volume":"16","author":"Chen YC","year":"2015","journal-title":"BMC Nephrol"},{"key":"bibr50-20503121231166642","unstructured":"WHO. Guidelines on estimation of residual risk of HIV, HBV or HCV infections via cellular blood components and plasma. Geneva, Switzerland: WHO, 2016, pp. 1\u201334."},{"key":"bibr51-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2017.06.014"},{"issue":"21","key":"bibr52-20503121231166642","first-page":"1216","volume":"24","author":"Mawuena B","year":"2018","journal-title":"World J Urol"},{"key":"bibr53-20503121231166642","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S206870"},{"key":"bibr54-20503121231166642","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S336776"},{"key":"bibr55-20503121231166642","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005374"}],"container-title":["SAGE Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20503121231166642","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20503121231166642","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20503121231166642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:25:25Z","timestamp":1777595125000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20503121231166642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":55,"alternative-id":["10.1177\/20503121231166642"],"URL":"https:\/\/doi.org\/10.1177\/20503121231166642","relation":{},"ISSN":["2050-3121","2050-3121"],"issn-type":[{"value":"2050-3121","type":"print"},{"value":"2050-3121","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"article-number":"20503121231166642"}}